EDMONTON, Alberta, Nov. 15 /PRNewswire-FirstCall/ -- Medical Services International Inc. is pleased to announce that it has entered into a joint venture with a Chinese firm and a hospital located in northern China, whereby the Chinese firm and the hospital will act as joint distributors of the VScan products in northern China. The hospital will use the VScan products exclusively whenever possible. The hospital will also conduct any testing required in order to get any approvals required with regulatory agencies. By having the hospital conduct any testing required it will reduce the time that it normally takes to arrange testing as we will have access to an established patient base as well as modern laboratories to conduct the testing.
All previous contracts in China have been with provinces and hospitals in southern China. This is Medical Services’ first entrance into northern China. It is reasonable to expect that the Joint Venture will arrange significant contracts in Northern China that are comparable with the contracts in southern China. The southern China contracts are expected to generate in excess of $25 million US over three years.
About VScan
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol “MSITF”. For further information, please contact Robert Talbot at (780) 430 6363 or media contact Bill Whitehead at (416) 822 5883 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com .
NOTE: Certain statements in this press release are “forward-looking statements” within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
Medical Services International Inc.
CONTACT: Robert Talbot, +1-780-430-6363, or media, Bill Whitehead,+1-416-822-5883, both of Medical Services International Inc.
